Mohamad Mohty

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Mohamad Mohty
Jun 8, 2025, 16:55 | Insight
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of…
Jun 3, 2025, 15:42 | Opinion
Top 5 ASCO 2025 Myeloma Abstracts Suggested by Vincent Rajkumar
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…
May 31, 2025, 01:11 | Career
Mohamad Mohty: Proud of Prof Ali Bazarbachi, a newly elected member of the national academy of medicine in France
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Apr 29, 2025, 20:13 | Insight
Rachit Khandelwal shares 2025 breakthrough update on Sinusoidal Obstruction Syndrome post-HSCT
Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, shared a post on X about…
Apr 24, 2025, 17:06 | Blog
Mohamad Mohty: Welcome to ⁦the World Congress on Controversies in Multiple Myeloma
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Apr 21, 2025, 11:43 | Blog
Mohamad Mohty: Registration is open for the IACH Roundtable Debate
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Apr 14, 2025, 10:30 | Blog
Mohamad Mohty: Discover the future of clinical hematology with the IACH
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Apr 3, 2025, 10:27 | Blog
Mohamad Mohty: A timely ⁦IACH webinar for EBMT 25
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Feb 13, 2025, 11:33 | Science
Mohamad Mohty: Frontline management of multiple myeloma patients
Mohamad Mohty, Chairman of the IACH, shared a post on X about a paper he…
Feb 6, 2025, 14:09 | Science
Mohamad Mohty: How to perform a high-quality peer review
Mohamad Mohty, Chairman of the IACH, shared his recent article on X: Just published in…
Jan 2, 2025, 16:09 | Blog
Save the date for the IACH's Post ASH24 Webinar
IACH shared a post on X: “Save the date for The IACH's Post ASH24 Webinar:…
Dec 31, 2024, 10:28 | Insight
Uriel Suárez: IACH News of the week
Uriel Suárez, Resident of hematology at Jiménez Díaz Foundation University Hospital, posted on X: “IACH…
Dec 26, 2024, 09:55 | Science
Mohamad Mohty: Delivering bad news in clinical hematology
Mohamad Mohty, Chairman of the IACH, shared a recent article on X: "Our work is…
Dec 16, 2024, 23:34 | Blog
Mohamad Mohty: Renewed sense of hope and purpose after ASH24
Mohamad Mohty, Chairman of the IACH, shared on X: "One week after the ASH24 annual…
Dec 13, 2024, 15:39 | Societies
Best of 66th ASH Annual Meeting and Exposition
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 11, 2024, 19:11 | Drugs
Results of AQUILA Trial: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Daratumumab, an anti-CD38 monoclonal antibody, has been approved for treating multiple myeloma. On December 9th…
Dec 10, 2024, 19:04 | Blog
Long-term follow-up of the COMMAND presented by Gullermo Garcia-Manero at ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 10, 2024, 16:55 | Societies
Highlights from Day 3 of ASH 2024
The 66th ASH Annual Meeting and Exposition held from December 7-10, 2024, in San Diego,…
Dec 10, 2024, 12:21 | Insight
Mohamad Mohty: The breaking news of the day at ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 10, 2024, 10:40 | Insight
Highlights from ASH24 Day 2
The 66th ASH Annual Meeting and Exposition, is being held from December 7-10, 2024, in…
Dec 8, 2024, 06:11 | Societies
Highlights from Day 1 of ASH 2024 Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is being held from…
Dec 6, 2024, 10:29 | Blog
Mohamad Mohty: Reflections before the start of ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 2, 2024, 19:20 | Blog
Mohamad Mohty: IACH Webinar series, High-Quality peer review, a few tips
Mohamad Mohty, Professor of Hematology at Sorbonne University and Head of the Clinical Hematology and Cellular…
Nov 25, 2024, 17:34 | Insight
Saad Z. Usmani: Engaging discussions at this year’s Myeloma Meeting
Saad Z. Usmani, Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center, shared…
Oct 14, 2024, 15:42 | Blog
IACH - Targets and Treatments in Primary CNS Lymphoma with Carole Soussain and Mohamad Mohty
IACH shared on X: '' Join us for the upcoming IACH Journal Club Targets and…
Oct 7, 2024, 14:37 | Societies
Highlights from The 7th Translational Research Conference on Multiple Myeloma (ESHMM2024)
The 7th Translational Research Conference on Multiple Myeloma (ESHMM2024) took place from October 04-06, 2024,…
Sep 27, 2024, 12:51 | Blog
Mohamed Kharfan-Dabaja: Management of R/R mantle cell lymphoma by Amer Beitinjaneh at the IACH2024
Mohamed Kharfan-Dabaja shared a post on X: "Outstanding presentation on management of relapsed/refractory mantle cell…
Sep 26, 2024, 14:03 | Blog
Mohamad Mohty: The new ⁦IACH⁩ platform is live
Mohamad Mohty, Professor of Hematology at Sorbonne University and Head of the Clinical Hematology and…
Sep 22, 2024, 17:05 | Societies
20 Posts Not To Miss From IACH2024
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL, COLYM, and MPNCo&D tracks,…
Sep 21, 2024, 14:48 | Career
Naveen Pemmaraju receives the IACH 2024 Special Achievement Award
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL,…
Aug 17, 2024, 07:45 | Insight
Razan Mohty: Outcomes of patients with IDH1 or 2 mutated AML after alloHCT
Razan Mohty, Assistant Professor at UAB Medicine, shared a post on X about a recent…
Aug 4, 2024, 07:01 | Insight
Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission
Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X: "Allogeneic…
Aug 1, 2024, 04:58 | Insight
Real-world data to describe myeloma management and outcomes
Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne…
Jul 23, 2024, 13:09 | Blog
Mohamad Mohty: Very special and timely webinar for practicing hematologists by IACH
Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne…
Jul 15, 2024, 02:35 | Insight
The latest IACH Post-Congress Webinars
International Academy for Clinical Hematology (IACH) Shared on X: “Our latest IACH Post-Congress Webinars: Multiple…
Jul 10, 2024, 00:26 | Blog
Myeloma podcast on BCMA-targeting bispeciifc antibodies - VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) shared on X: "Did you know…
Jul 1, 2024, 13:39 | Blog
Mohamad Mohty: Comprehensive review of Multiple Myeloma published in ⁦Nature Reviews Disease Primers⁩
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Jun 28, 2024, 14:06 | Blog
Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer
Vincent Rajkumar shared a post on X: “Cure is a simple word. But there is…
Jun 20, 2024, 13:18 | Insight
Myeloma Paper of the Day, June 20th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Long-term follow-up of Phase III…
Jun 20, 2024, 12:25 | Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
Jun 20, 2024, 11:53 | Blog
Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study - Multiple Myeloma Hub
Multiple Myeloma Hub shared on X/Twitter: "CONGRESS | POSTER | EHA2024 | Mohamad Mohty shares long-term…
Jun 20, 2024, 03:53 | Insight
Gregorio Maria Bergonzi: EHA2024 has come to an end
Gregorio Maria Bergonzi, Hematology Resident at IRCCS San Raffaele Hospital, made the following post on…
Jun 15, 2024, 07:24 | Blog
Gregorio Maria Bergonzi: Excited to attend EHA2024
Gregorio Maria Bergonzi, Hematology Resident at IRCCS San Raffaele Hospital, made the following post on…
Jun 13, 2024, 05:46 | Societies
Carl Ola Landgren: Getting ready with Mohamad Mohty for tomorrow’s opening session at EHA2024
Carl Ola Landgren shared on X: "Getting ready together with Mohamad Mohty for tomorrow’s opening…
Jun 4, 2024, 14:44 | Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
May 30, 2024, 09:56 | Blog
Joseph Mikhael: Such a wonderful meeting in Paris COMy Congress
Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, shared a post on X:…
May 27, 2024, 03:45 | Blog
Joshua Richter: Beyond honored to be working with giants of myeloma
Joshua Richter, Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical…
Jan 21, 2024, 15:31 | Blog
Humaid Al-Shamsi: I was honored to meet with our role models and world expert in BMT, Mohamad Mohty and Ali Bazarbashi
Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared a post on…
Jan 11, 2024, 18:11 | Blog
Amer Zeidan: Dr Mohamad Mohty continues to lead high value educational initiatives globally and in Middle East
Amer Zeidan, Associate Professor of Hematology at Yale University, shared a post on LinkedIn: "Dr Mohamad…
Dec 24, 2023, 16:02 | Blog
Mohamad Mohty: Getting ready for «the mission»
Mohamad Mohty, Professor of Hematology at Sorbonne University, and Head of the Clinical Hematology and…
Oct 25, 2023, 17:36 | Blog
Naveen Pemmaraju: Shout out to my fellow co-founding moderators for the successful first-in-person MPN Co&D meeting in Paris.
Naveen Pemmaraju shared on Twitter: "Shout out to my fellow co-founding moderators for the successful…
Oct 11, 2023, 19:22 | Blog
Naveen Pemmaraju: I was honored to Co-Chair the Inaugural in-person MPNCo and D Meeting October 2023 with Prof Ruben Mesa, MD and Prof Claire Harrison this week in Paris, France
Jul 7, 2023, 06:06 | Blog
This is a nice example showing that academic and commercial CAR-T cells can co-exist - Mohamad Mohty
This is a nice example showing that academic and commercial CAR-T cells can co-exist. Congratulations…
All: 53 Posts: 1 - 100
Special Coverage